Massachusetts Financial Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$110M Sell
396,150
-3,057
-0.8% -$880K 0.04% 345
2025
Q4
$121M Buy
399,207
+390,593
+4,534% +$122M 0.04% 352
2025
Q3
$2.42M Buy
8,614
+4,888
+131% +$1.33M ﹤0.01% 751
2025
Q2
$899K Sell
3,726
-536
-13% -$127K ﹤0.01% 821
2025
Q1
$1.04M Buy
4,262
+665
+18% +$200K ﹤0.01% 807
2024
Q4
$1.18M Sell
3,597
-50,566
-93% -$17.2M ﹤0.01% 805
2024
Q3
$18.1M Sell
54,163
-294,377
-84% -$93.5M 0.01% 605
2024
Q2
$95.2M Buy
348,540
+1,288
+0.4% +$375K 0.03% 381
2024
Q1
$120M Buy
347,252
+24,958
+8% +$8.21M 0.04% 353
2023
Q4
$104M Sell
322,294
-1,423
-0.4% -$446K 0.03% 374
2023
Q3
$116M Buy
+323,717
New +$125M 0.04% 339

Other funds holding BIO